- FDA approves first treatment for patients with rare type of lung disease🔍
- detecting poor lung health early to help prevent disease in later life🔍
- Interstitial Lung Disease🔍
- Respiratory Health in Cerebral Palsy🔍
- Professor Nancy Ip🔍
- Chronic obstructive pulmonary disease 🔍
- Restrictive lung disease🔍
- Obstructive vs. Restrictive Lung Diseases🔍
Pioneering Paths for Lung Diseases
FDA approves first treatment for patients with rare type of lung disease
... options to scleroderma patients,” said Nikolay Nikolov, M.D., associate director for Rheumatology of the Division of Pulmonary, Allergy, and ...
detecting poor lung health early to help prevent disease in later life
The pathways could also be used to spot those at higher risk of lung disease at an earlier stage, resulting in earlier diagnosis and more treatment options for ...
Interstitial Lung Disease: A Review - JAMA Network
First-line therapy includes nintedanib or pirfenidone for IPF and mycophenolate mofetil for ILD due to connective tissue disease. Lung ...
Respiratory Health in Cerebral Palsy | AACPDM - AACPDM
Corbett Ryan Pathways Pioneer Award · Fred P. Sage Award · Lifetime Achievement ... This may lead to suppurative lung disease, bronchiectasis, and obstructive ...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative ...
Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative Alzheimer's disease ...
Chronic obstructive pulmonary disease (COPD) and lung cancer
Further understanding of the shared molecular pathways between these two lung diseases ... First National Health and Nutrition Examination Survey follow-up.
Restrictive lung disease: Types, causes, and treatments
Restrictive lung diseases prevent the lungs from expanding fully. Some examples include sarcoidosis and idiopathic pulmonary fibrosis.
Obstructive vs. Restrictive Lung Diseases: Causes and Treatment
... first second of the FVC test. Healthy people ... Restrictive Lung Disease. Treatment options for restrictive lung diseases are more limited.
Stage 1 (Mild) Emphysema - WebMD
Lung Disease & Respiratory Health/; COPD/; Reference/. Stage 1 (Mild) ... But you might not know you have the disease for the first few years ...
Chronic Obstructive Pulmonary Disease (COPD): Diagnosis and ...
Better Breathers Club: Support groups for individuals with chronic lung disease and their caregivers. Learn better ways to cope with conditions ...
Infant Chronic Lung Disease | Children's Hospital of Philadelphia
Clinical pathways · Ways to Give · Get involved · Make a gift. Sign up for newsletters. Be among the first to know about our latest breakthroughs. Subscribe ...
How a new drug prototype regenerates lung tissue - Scripps Research
For many progressive lung diseases like idiopathic pulmonary fibrosis ... “IPF makes the most sense as the first disease to investigate ...
Julie Avery (she/her/hers) on LinkedIn: Pioneering Paths for Lung ...
Julie Avery (she/her/hers)'s Post · Pioneering Paths for Lung Diseases · More Relevant Posts · FDA Grants Fast Track Designation to ANPD001, Autologous ...
Respiratory Medicine | Journal | ScienceDirect.com by Elsevier
... respiratory diseases and therapeutic interventions.… View full aims & scope. $3520. Article publishing charge for open access. 17 days. Time to first decision.
Pioneers in Asthma: Where is the science leading us? - AstraZeneca
... diseases that share common pathways and disease drivers.9,14 By ... Observational Study of Obstructive Lung Disease (NOVELTY).
Bronchopulmonary Dysplasia (BPD) (for Parents) - Kids Health
Bronchopulmonary dysplasia (BPD), sometimes called chronic lung disease, is a problem with how a baby's lung tissue develops.
A Path to Tackling Common Illness | Flagship Pioneering
... respiratory diseases, kidney failure, schizophrenia, and depression. It is absolutely critical to develop effective ways to prevent or treat ...
Lighting a new path in innovation, Atlantic Health System deploys ...
Using a shape-sensing catheter system, pulmonologists and thoracic surgeons at both campuses will be able to reach inside the lungs with more ...
Genentech's Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults.
Lung microbiome: new insights into the pathogenesis of respiratory ...
First, lung microbes and their ... Chronic obstructive pulmonary disease (copd) and lung cancer: Common pathways for pathogenesis.